1Keller MB. Raising the expectations of long-term treatment strategies in anxiety disorders [J]. Psychopharmaeol Bull, 2002,36(Suppl 2) :166-174. 被引量：1
2Eisen JL, Goodman WK, Keller MB, et al. Patterns of remission and relapse in obsessive-compulsive disorder:a 2- year prospective study[J]. J Clin Psychiatry, 1999,60 (5) : 346- 351. 被引量：1
3Ballenger JC. Current treatment of the anxiety disorders in adults[J]. Biol Psychiatry, 1999,46(11) : 1579-1594. 被引量：1
4Kessler RC,Sonnega A, Bromet E, et al. Posttraumatic stress disorder in the National Comorbidity Survey[J]. Arch Gen Psychiatry, 1995,52(12) : 1048-1060. 被引量：1
5Roy Byrne PP, Stang P, Wittchen HU, et al. Lifetime panicdepression comorbidity in the National Comorbidity Survey [J]. Br J Psychiatry,2000,176(3) :229-235. 被引量：1
6Stein MB, Kean YM. Disability and quality of life in social phobia: epidemiologic findings[J]. Am J Psychiatry, 2000,157 (10):1606- 1613. 被引量：1
7Wittehen H U, Zhao S, Kessler RC, et al. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey[J]. Arch Gen Psychiatry,1994,51(5) :355-364. 被引量：1
8Carson W H,Kitagawa H,Nemeroff CB. Drug development for anxiety disorders: new roles for atypical antipsychotics[J]. Psychopharmacol Bull, 2004,38 (Suppl 1 ) : 38-45. 被引量：1
9Wilner KD, Anziano RJ, Johnson AC, et al. The anxiolytic effect of the novel antipsychotic ziprasidone compared with diazepam in subjects anxious before dental surgery[J]. J Clin Psychopharmacol, 2002,22 (2) : 206-210. 被引量：1
10Arnt J, Skarsfeldt T. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence[J]. Neuropsychopharmacol, 1998,18(2):63 -101. 被引量：1
2Yi LT, Wang X, Wang Y, et al. Antidepressant -like Effects of Monarch Drug Compatibility in Banxia Houpu Decoction [ J ]. Chinese Journal of Natural Medicines, 2010, 8 (8) : 362 -369. 被引量：1
